Processa Pharmaceuticals, Inc. (PCSA)
NASDAQ: PCSA · Real-Time Price · USD
2.160
+0.190 (9.64%)
At close: Jul 10, 2026, 4:00 PM EDT
2.130
-0.030 (-1.39%)
After-hours: Jul 10, 2026, 5:45 PM EDT
Processa Pharmaceuticals Market Cap
Processa Pharmaceuticals has a market cap or net worth of $5.94 million as of July 10, 2026. Its market cap has increased by 91.62% in one year.
Market Cap
5.94M
Enterprise Value
4.25M
1-Year Change
91.62%
Ranking
Category
Stock Price
$2.16
Market Cap Chart
Since October 2, 2020, Processa Pharmaceuticals's market cap has decreased from $34.40M to $5.94M, a decrease of -82.73%. That is a compound annual growth rate of -26.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 5.94M | -8.61% |
| Dec 31, 2025 | 6.50M | 124.14% |
| Dec 31, 2024 | 2.90M | -64.63% |
| Dec 29, 2023 | 8.20M | -53.41% |
| Dec 30, 2022 | 17.60M | -77.14% |
| Dec 31, 2021 | 77.00M | 10.47% |
| Dec 31, 2020 | 69.70M | 102.62% |
| Oct 2, 2020 | 34.40M | - |
View and export this data all the way back to 2020. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Aptevo Therapeutics | 5.64M |
| Soligenix | 5.62M |
| Dermata Therapeutics | 5.39M |
| Liminatus Pharma | 5.33M |
| PMGC Holdings | 5.32M |
| Enveric Biosciences | 5.30M |
| HCW Biologics | 5.25M |
| CollPlant Biotechnologies | 5.11M |